CPClin – Centro de Pesquisas Clinicas LTDA
CPClin – Centro de Pesquisas Clinicas LTDA
Avenida Angélica, 2162 – Consolação – São Paulo, SP, CEP:01228-200
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Denise Reis Franco
Carlo Bonasso Filho
Carla Herrmann Monteiro
Lilian Peres da Silva
Risoneide Batista
Renata de Carvalho Camara
Ana Paula Britto Gomes Botturi Cavalcante
Lea Bonfim Luz Mori
Rafaella Felippe Palazzi
Celia Regina Echeverria Sampaio
Vanessa de Oliveira Magalhaes
Mateus Boaventura
Maria Salete Garcez
Alinede Moura Brasil Matos
Lucas Bueno Feo
Anísio Moraes Junior
Flavia Moraes
Mauricio Pedrosa
Vinicius de Oliveira
Larissa Barbosa Parra Ribeiro
Maria Salete Siraque Garcez
Gabriela Heleno Chaves
Jonathan Bastos Rosseti
Daniela Ruiz Rett
Open studies
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Alzheimer disease
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease - TRONTIER 1 - Hoffmann-La RocheSee more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Extrapyramidal and movement disorders
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease - PARAISO - Hoffmann-La RocheSee more
Diabetes
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI) - MicuRxSee more
